Connect to other sites within the UBM Medica Network
This Special Report reviews the latest pharmacological strategies for anxiety, comorbid anxiety and schizophrenia, TMS, and managing anxiety in the medically ill.
Pharmacological Strategies for Generalized Anxiety Disorder
Treatment approaches to GAD, a highly prevalent, chronic, debilitating, relapsing, and often underdiagnosed anxiety disorder.
Treating Comorbid Anxiety Disorders in Patients With Schizophrenia: A New Pathway
Identifying comorbid anxiety disorders as potential treatment targets may contribute to more positive outcomes for patients with schizophrenia. Details here.
Does TMS Hold Promise for Generalized Anxiety Disorder?
Available data suggest that transcranial magnetic stimulation holds promise as a treatment for GAD. Here: a look at what we know.
Managing Anxiety in the Medically Ill
The authors examine anxiety in the medically ill: its presence secondary to or as an impersonator of physical illness and its diagnostic and management challenges.
Introduction: Risk Factors, Pharmacological Interventions, and Sequelae of Suicidal Behavior
The articles in this Special Report address suicidal behavior in the context of the role of sexual identity, the effects of antidepressants and lithium on suicidal behavior, and clinicians’ reactions in the aftermath of suicide.
What Role Does (Should) Lithium Play in Suicide Treatment/Prevention?
An interesting pharmacological approach in terms of anti-suicidal strategies is the use of lithium for treatment of patients with affective disorders. Details here.
Patient Suicide: Impact on Clinicians
As an occupational hazard, preparing for the possibility of patient suicide will help the clinician anticipate the types of support that our colleagues or we may need to weather the event.
Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.
By clicking Accept, you agree to become a member of the UBM Medica Community.